4
Changes in Ownership
Lucid Diagnostics Inc. Filed Acc 0001062993-22-005482
Options or other derivatives
- Chief Executive Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Aklog Lishan Chief Executive Officer | 2022-02-18 | Grant or award · Employee stock option (right to buy) | +75,000 | 75,000 | D | ||
Loading xslF345X03/form4.xml…